Acelyrin (NASDAQ:SLRN) traded sharply lower on Tuesday after the company and its California-based rival Alumis (NASDAQ:ALMS) reaffirmed their commitment to merge in line with their previously ...

ACELYRIN (SLRN) (ISIN: US00445A1007)股票专题，提供今日ACELYRIN(SLRN) (ISIN: US00445A1007)股票最新股价查询，实时市场行情，走势图表，及ACELYRIN Inc(SLRN) (ISIN: US00445A1007)股票的专业技术分析，投资者论坛，历史交易数据，最新消息和未来价格预测。

The open-back detailed showed off her back tattoos including a the Arabic words that translate to "love yourself first" below her right shoulder and her elaborate dripping rose tattoo at behind ...

Shares of Acelyrin, Inc. (NASDAQ: SLRN) increased 12.44% to $2.44 on Thursday after an equity-related development was confirmed. An unsolicited takeover offer from Concentra Biosciences, LLC, a ...

LOS ANGELES, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative ...

LOS ANGELES, Feb. 20, 2025 (GLOBE NEWSWIRE) -- ACELYRIN, INC. (Nasdaq: SLRN), a late-stage clinical biopharma company focused on accelerating the development and delivery of transformative medicines ...

Irish native who switched from the music industry to the world of sport moving from Universal Music to AS in 2017. A keen runner, soccer player and now discovering the world's fastest growing ...

NEW YORK, Feb. 18, 2025 (GLOBE NEWSWIRE) -- Kuehn Law, PLLC, a shareholder litigation law firm, is investigating potential claims related to the below-listed proposed mergers. Kuehn Law may seek ...

ACELYRIN, INC. (NASDAQ: SLRN)'s sale to Alumis Inc. for 0.4274 shares of Alumis common stock for each share of ACELYRIN common stock. If you are an ACELYRIN shareholder, click here to learn more ...